Results from the latest amyloid-busting dementia drug trial may spur efforts at earlier diagnosis.
Results from the latest amyloid-busting dementia drug trial may spur efforts at earlier diagnosis.
End of content
No more pages to load
From The Source
- DoHAC: Four new Medicare Mental Health Centres for North Brisbane and Moreton Bay
- Australian Medical Council annual report
- Ramsay Health Care: Armidale Private Hospital doc celebrates 1,000 new knees
- Botanix Pharmaceuticals: First Sofdra prescriptions as commercialisation ramps up
- Botanix Pharmaceuticals: First Sofdra prescriptions as commercialisation ramps up
- DoHAC: Aged Care Transition Taskforce Summary of Meeting – 11 December 2024
- AAHMS: Academy calls for a national human biomonitoring program to track the health impacts of forever chemicals
- DoHAC: Strengthening Medicare – General Practice Grants Program Evaluation: Final Report
- Novotech Named a Fierce CRO Award Winner in the Excellence in Clinical Trial Management and Global Operations Categories
- Have ED times really improved enough to prevent another child’s death?
- NDIS gets $1b injection to slow growth even as budget slides into deficit
- Peter MacCallum Cancer Centre: IMCT Network Refresh